110 related articles for article (PubMed ID: 25284084)
21. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
[TBL] [Abstract][Full Text] [Related]
22. Andersen-Tawil syndrome: management challenges during pregnancy, labor, and delivery.
Subbiah RN; Gula LJ; Skanes AC; Krahn AD
J Cardiovasc Electrophysiol; 2008 Sep; 19(9):987-9. PubMed ID: 18554214
[TBL] [Abstract][Full Text] [Related]
23. Andersen cardiodysrhythmic periodic paralysis with KCNJ2 mutations: a novel mutation in the pore selectivity filter residue.
Lim BC; Kim GB; Bae EJ; Noh CI; Hwang H; Kim KJ; Hwang YS; Ko TS; Chae JH
J Child Neurol; 2010 Apr; 25(4):490-3. PubMed ID: 20382953
[TBL] [Abstract][Full Text] [Related]
24. Neurophysiologic characterization of periodic paralysis episode in a patient with Andersen-Tawil syndrome.
Falcão de Campos C; de Carvalho M
Clin Neurophysiol; 2018 Mar; 129(3):558-559. PubMed ID: 29353185
[No Abstract] [Full Text] [Related]
25. [A new type of periodic paralysis: Andersen-Tawil syndrome].
Pouget J
Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
[TBL] [Abstract][Full Text] [Related]
26. Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome.
Ballester LY; Benson DW; Wong B; Law IH; Mathews KD; Vanoye CG; George AL
Hum Mutat; 2006 Apr; 27(4):388. PubMed ID: 16541386
[TBL] [Abstract][Full Text] [Related]
27. Intrafamilial phenotypic variability in Andersen-Tawil syndrome: A diagnostic challenge in a potentially treatable condition.
Ardissone A; Sansone V; Colleoni L; Bernasconi P; Moroni I
Neuromuscul Disord; 2017 Mar; 27(3):294-297. PubMed ID: 28024840
[TBL] [Abstract][Full Text] [Related]
28. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
[TBL] [Abstract][Full Text] [Related]
29. Andersen-Tawil syndrome with early fixed myopathy.
Lefter S; Hardiman O; Costigan D; Lynch B; McConville J; Hand CK; Ryan AM
J Clin Neuromuscul Dis; 2014 Dec; 16(2):79-82. PubMed ID: 25415519
[TBL] [Abstract][Full Text] [Related]
30. Mind the Gap: Acetazolamide Prolonged Periods without Paralysis in a Girl with Andersen-Tawil Syndrome.
Žakelj N; Osredkar D; Šuštar N
Case Rep Neurol; 2021; 13(2):515-520. PubMed ID: 34720956
[TBL] [Abstract][Full Text] [Related]
31. A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome.
Chan HF; Chen ML; Su JJ; Ko LC; Lin CH; Wu RM
J Hum Genet; 2010 Mar; 55(3):186-8. PubMed ID: 20111058
[TBL] [Abstract][Full Text] [Related]
32. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
33. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome.
Doi T; Makiyama T; Morimoto T; Haruna Y; Tsuji K; Ohno S; Akao M; Takahashi Y; Kimura T; Horie M
Circ Cardiovasc Genet; 2011 Jun; 4(3):253-60. PubMed ID: 21493816
[TBL] [Abstract][Full Text] [Related]
34. [A case of hypokalemic periodic paralysis: utility of exercise test for the assessment of therapeutic efficacy].
Watanabe M; Hasegawa T; Takeda A; Shiga Y; Itoyama Y
No To Shinkei; 2003 Jun; 55(6):527-9. PubMed ID: 12884806
[TBL] [Abstract][Full Text] [Related]
35. Muscle weakness, palpitations and a small chin: the Andersen-Tawil syndrome.
Rajakulendran S; Tan SV; Hanna MG
Pract Neurol; 2010 Aug; 10(4):227-31. PubMed ID: 20647529
[TBL] [Abstract][Full Text] [Related]
36. Effect of flecainide on T-wave alternans in Andersen-Tawil syndrome.
Hayashi H; Kawaguchi T; Horie M
Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):383-6. PubMed ID: 25040481
[No Abstract] [Full Text] [Related]
37. An unusual case of recurrent episodes of muscle weakness: Co-occurrence of Andersen-Tawil syndrome and glycogen storage disease type IXd.
Li H; Xue Y; Yu J; Guo S; Liu C
Neuromuscul Disord; 2020 Jul; 30(7):562-565. PubMed ID: 32660786
[TBL] [Abstract][Full Text] [Related]
38. Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome.
Sumitomo N; Shimizu W; Taniguchi K; Hiraoka M
Heart Rhythm; 2008 Mar; 5(3):498-9. PubMed ID: 18313615
[No Abstract] [Full Text] [Related]
39. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
Tani Y; Miura D; Kurokawa J; Nakamura K; Ouchida M; Shimizu K; Ohe T; Furukawa T
J Mol Cell Cardiol; 2007 Aug; 43(2):187-96. PubMed ID: 17582433
[TBL] [Abstract][Full Text] [Related]
40. Response to flecainide test in Andersen-Tawil syndrome with incessant ventricular tachycardia.
Fernández M; Marín MDR; Fernández-Armenta J; Mora-López F; Fernández Rivero R; Berruezo A; Cano Calabria L; Vázquez García R
Pacing Clin Electrophysiol; 2018 Apr; 41(4):429-432. PubMed ID: 29023786
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
